Is Northern Potash Co. (NPTH) a Buy, Sell, or Hold?
OTC : NPTH
Northern Potash Co. — News
$0.0003 USD
$0 (0.0%)
- Volume
- 2K
- Average Volume
- 32
- Market Capitalization
- $13.66K
- P/E Ratio
- -60.72
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
| Source | Headline |
|---|---|
|
NEUPATH HEALTH ANNOUNCES VOTING RESULTS FROM THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
TORONTO--(BUSINESS WIRE)---- $NPTH--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), operates one of Canada's largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 10, 2026 and the grant of restricted share units (“RSU. businesswire.com - 2026-06-11 07:30:00 |
|
NEUPATH HEALTH REPORTS FIRST QUARTER 2026 RESULTS
TORONTO--(BUSINESS WIRE)---- $NPTH--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada's largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced its financial and operating results for the three months ended March 31, 2026 and information regarding the Company's investor webinar on Thursday, May 14, 2026. A. businesswire.com - 2026-05-14 07:30:00 |
